Skip to content

Greenwich LifeSciences, Inc.

GLSI· NasdaqCore metricsCIK 1799788

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -6.79%
Market cap
$222.67M
14.68M shares
Filings
280
—
—
—
-$5.81M
Q3 2026N/M FY25 yoy
-$5.86M
Q3 2026N/M FY25 yoy
—
—
—
-$0.40
Q3 2026N/M FY25 yoy
$5.90M
Q3 2026+51.0% FY25 yoy
$222.67M
—
—
—
—
—

FY2025 figures · derived

Price

$15.17+79.10%+$6.70past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$17.22MFY 2025
$17.22M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$17,220,401reported
FY 20242024-12-31$15,480,217 revisedreported
FY 20232023-12-31$7,698,622reported
FY 20222022-12-31$6,475,668reported
FY 20212021-12-31$3,559,515reported
FY 20202020-12-31$1,057,606reported
FY 20192019-12-31$2,606,420reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2022—$7.54M$7.54M—12.85M sh−0.8%—

Pharmaceutical preparations

Greenwich LifeSciences, Inc. is the 243rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR